Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Cilo Cybin Holdings Ltd (CCC.JO)
Centurion, ZA
Cilo Cybin Holdings Limited is an international enterprise focused on the cultivation, production, and distribution of medicinal cannabis products. Its extensive catalog includes bottled THC and CBD oils, cannabis flowers, and vaping solutions. The company further supplies tinctures, edibles, topical applications, capsules, and specialized devices. Additionally, they manufacture a variety of advanced cannabis extracts, such as full and broad-spectrum refined crude oil, CBD and THC distillates, and pure isolates of CBD, CBG, CBN, and THC. Beyond its product offerings, Cilo Cybin provides essential support services to the cannabis industry, encompassing packaging, storage, and export facilitation. Consumers can directly acquire these goods through its dedicated online retail channel, known as the Brand Shop. Founded in 2018, the firm maintains its base of operations in Centurion, South Africa.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -5.26% | -10.00% | +9,900.00% | -55.00% | -58.72% | -58.14% | -69.49% | -57.65% | -57.65% | -57.65% | -57.65% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
-
Revenue growth Financial - Conglomerates: +32.7%—
-
EPS growth Financial - Conglomerates: +16.6%-219.7% Q3'25: -79,544.4% (vs Q4'23)
-
FCF margin FCF growth · Financial - Conglomerates: +2.3%— Q3'25: +10.2% (vs Q4'23)
-
EBIT margin Financial - Conglomerates: +36.2%— Q3'25: -1,148.9% (vs Q4'23)
-
ROIC Financial - Conglomerates: +2.2%-9.1% Q3'25: -1,648.1% (vs Q4'23)
-
Share dilution Financial - Conglomerates: +0.0%+8.3% Q3'25: +16.0% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Financial - Conglomerates: 2.57×43.71× ★ Q3'25: -0.01× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-06-19 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-06-18 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-06-17 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-06-05 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-06-03 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-07 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-04 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-29 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-16 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Gabriel Christiaan Theron | Founder, Chief Executive Officer & Executive Director | 2M | male |
| Reshoketswe Maggy Ledwaba | Executive Officer | 1M | female |
| Christina Pretorius | Head of Quality & Compliance | — | — |
| Dimitri Shokkos | Head of Cultivation & Cannabis Specialist | — | male |
| Jessica Moodley-Theron | Acting CFO & Financial Director and Executive Director | — | female |
| Rouxne Styger | Company Secretary | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for CCC.JO
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
